Clinical trial
BAY59-7939, Japanese Phase II in Atrial FibrillationTrial Status
NCT00779064 is registered in ClinicalTrials.gov with Bayer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BAY59-7939, Japanese Phase II in Atrial FibrillationTrial Status
- Lead sponsor
- Bayer
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2004
- Completion date
- June 30, 2005
- Enrollment
- 36 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.